1
|
Topical delivery of 3,5,4'-trimethoxy-trans-stilbene-loaded microemulsion-based hydrogel for the treatment of osteoarthritis in a rabbit model. Drug Deliv Transl Res 2019; 9:357-365. [PMID: 30430453 DOI: 10.1007/s13346-018-00604-z] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The aim of this study was to develop a microemulsion-based hydrogel (MBH) formulation of 3,5,4'-trimethoxy-trans-stilbene (BTM) as topical delivery system for the treatment of osteoarthritis (OA). The pseudo-ternary phase diagrams were constructed to optimize the microemulsion (ME) formulation. The ME formulation containing 18.8% Cremopher EL35 (surfactant), 9.4% Transcutol HP (co-surfactant), 3.1% LABRAFIL M 1944 CS (oil), and 68.7% water was selected. The obtained BTM-loaded ME (BTM-ME) had a spherical morphology (17.5 ± 1.4 nm), with polydispersity index (PDI) value of 0.068 ± 0.016 and zeta potential of - 11.8 ± 0.5 mV, and was converted into BTM-loaded MBH (BTM-MBH) using Carbopol 940. Ex vivo skin permeation study showed that both ME and MBH formulations significantly enhanced the amount of BTM permeated. The cumulative amount of BTM permeated after 12 h (Q12) for ME, and MBH formulations were 3.25- and 1.96-fold higher than that for emulsion gel (EG). Pharmacokinetic study showed that the AUC of BTM suspension (oral) was three times higher than that of BTM-MBH (topical). Topical delivery of BTM-MBH demonstrated remarkable anti-OA effect in a rabbit model of OA induced by papain, with decreased levels of pro-inflammatory cytokines. The developed MBH formulation might be a promising strategy for topical delivery of BTM for treatment of OA.
Collapse
|
2
|
Canela MD, Bueno O, Noppen S, Sáez Calvo G, Estévez Gallego J, Díaz JF, Camarasa MJ, Liekens S, Pérez-Pérez MJ, Priego EM. Targeting the colchicine site in tubulin through cyclohexanedione derivatives. RSC Adv 2016. [DOI: 10.1039/c5ra26807a] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Cyclohexanedione derivatives, a new family of colchicine-site binders, have been further explored with the aid of docking studies, resulting in compounds with improved solubility and Ka value for tubulin.
Collapse
Affiliation(s)
| | - Oskía Bueno
- Instituto de Química Médica (IQM-CSIC)
- E-28006 Madrid
- Spain
| | - Sam Noppen
- KU Leuven – University of Leuven
- Rega Institute for Medical Research
- B-3000 Leuven
- Belgium
| | | | | | - J. F. Díaz
- Centro de Investigaciones Biológicas (CIB-CSIC)
- E-28040 Madrid
- Spain
| | | | - Sandra Liekens
- KU Leuven – University of Leuven
- Rega Institute for Medical Research
- B-3000 Leuven
- Belgium
| | | | | |
Collapse
|
3
|
Design, synthesis and anti-proliferative effects in tumor cells of new combretastatin A-4 analogs. CHINESE CHEM LETT 2015. [DOI: 10.1016/j.cclet.2015.05.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
4
|
Álvarez R, Puebla P, Díaz JF, Bento AC, García-Navas R, de la Iglesia-Vicente J, Mollinedo F, Andreu JM, Medarde M, Peláez R. Endowing Indole-Based Tubulin Inhibitors with an Anchor for Derivatization: Highly Potent 3-Substituted Indolephenstatins and Indoleisocombretastatins. J Med Chem 2013; 56:2813-27. [DOI: 10.1021/jm3015603] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Raquel Álvarez
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Pilar Puebla
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | | | - Ana C. Bento
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Rósula García-Navas
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Janis de la Iglesia-Vicente
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Faustino Mollinedo
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | | | - Manuel Medarde
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Rafael Peláez
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| |
Collapse
|
5
|
Hsu LC, Durrant DE, Huang CC, Chi NW, Baruchello R, Rondanin R, Rullo C, Marchetti P, Grisolia G, Simoni D, Lee RM. Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor. Invest New Drugs 2011; 30:1379-88. [PMID: 21655917 DOI: 10.1007/s10637-011-9702-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2011] [Accepted: 06/02/2011] [Indexed: 11/30/2022]
Abstract
Hemiasterlins are cytotoxic tripeptides with antimicrotubule activity originally isolated from marine sponges. We have developed new hemiasterlin derivatives BF65 and BF78 that are highly potent to induce cancer cell death in the low nanomolar range. Examination of their mechanisms of cell cycle arrest and disruption of microtubules revealed an unusual characteristic in addition to anti-tubulin effect. Immunofluorescence staining revealed that A549 lung carcinoma cells treated with BF65 or BF78 exhibited both monopolar and multipolar mitotic spindles. Centrosomes were separated with short spindle microtubules in cells with multipolar spindles. In vitro tubulin polymerization assay confirmed that both BF65 and BF78 were highly potent to inhibit tubulin polymerization. These two compounds induced the formation of monoastral spindles suggesting that they might be inhibitors of mitotic kinesins such as KSP/Eg5. However, kinetic measurement of microtubule activated kinesin ATPase activity demonstrated that unlike the positive control monastrol, neither BF65 nor BF78 suppressed KSP/Eg5 activity. Hence the effect may be a variant form of tubulin inhibition. Similar to vinca alkaloids, BF compounds synergized with a colchicine site microtubule inhibitor stilbene 5c both in vitro and in vivo, which may provide a potential drug combination in the future clinical application.
Collapse
Affiliation(s)
- Lih-Ching Hsu
- School of Pharmacy, National Taiwan University, 12F, No 1, Section 1, Jen-Ai Road, Taipei 10051, Taiwan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Falciani C, Brunetti J, Pagliuca C, Menichetti S, Vitellozzi L, Lelli B, Pini A, Bracci L. Design and In vitro Evaluation of Branched Peptide Conjugates: Turning Nonspecific Cytotoxic Drugs into Tumor-Selective Agents. ChemMedChem 2010; 5:567-74. [DOI: 10.1002/cmdc.200900527] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
7
|
Tripathi A, Durrant D, Lee RM, Baruchello R, Romagnoli R, Simoni D, Kellogg GE. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity. J Enzyme Inhib Med Chem 2010; 24:1237-44. [PMID: 19912057 DOI: 10.3109/14756360902787055] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The crucial role of the microtubule in cell division has identified tubulin as a target for the development of therapeutics for cancer; in particular, tubulin is a target for antineoplastic agents that act by interfering with the dynamic stability of microtubules. A molecular modeling study was carried out to accurately represent the complex structure and the binding mode of a new class of stilbene-based tubulin inhibitors that bind at the alphabeta-tubulin colchicine site. Computational docking along with HINT (Hydropathic INTeractions) score analysis fitted these inhibitors into the colchicine site and revealed detailed structure-activity information useful for inhibitor design. Quantitative analysis of the results was in good agreement with the in vitro antiproliferative activity of these derivatives (ranging from 3 nM to 100 muM) such that calculated and measured free energies of binding correlate with an r(2) of 0.89 (standard error +/- 0.85 kcal mol(-1)). This correlation suggests that the activity of unknown compounds may be predicted.
Collapse
Affiliation(s)
- Ashutosh Tripathi
- Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA, USA
| | | | | | | | | | | | | |
Collapse
|
8
|
Chen SM, Meng LH, Ding J. New microtubule-inhibiting anticancer agents. Expert Opin Investig Drugs 2010; 19:329-43. [DOI: 10.1517/13543780903571631] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|